Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and focal adhesion kinase (FAK) inhibition. Pursuing unexplored pathways demands that we’re purposeful in everything we do. And it’s an endeavor that’s only possible with an experienced team of employees and partners dedicated to a singular purpose: changing and improving the way cancer is treated by delivering novel therapies that address areas of high unmet need in RAS pathway-driven cancers. At Verastem Oncology, it takes our diversity of backgrounds, expertise, perspectives, and skills to find the answers that patients need, but don’t have—yet. To join our team or for more information, please visit www.verastem.com. Twitter: @VerastemOncolog
Free account • No credit card • 5 profiles/day
The widely used Verastem Oncology email format is {first_initial}{last}@verastem.com (e.g. jsmith@verastem.com), which is used 100% of the time.
| Verastem Oncology Email Formats | Example Email Formats | Adoption |
|---|---|---|
| {first_initial}{last} | jsmith@verastem.com |
100%
|
Adoption = share of company emails using each format — not a verification or accuracy score.
Biotechnology Research • 11-50 employees • Boston, United States
Biotechnology Research • 51-200 employees • Alameda, United States
Biotechnology Research • 201-500 employees • Cambridge, United States
Biotechnology Research • 51-200 employees • San Diego, United States
Biotechnology Research • 11-50 employees • Menlo Park, United States
Biotechnology Research • 11-50 employees • Foster City, United States
What is Verastem Oncology email format?
The widely used Verastem Oncology email format is {first_initial}{last} (e.g. jsmith@verastem.com) with 100% adoption across the company.
What is Verastem Oncology customer service number?
To contact Verastem Oncology customer service number in your country click here to find.
Who are the decision makers in Verastem Oncology?
The decision makers in Verastem Oncology are Mike Crowther, Mark Wanda, John Hayslip, etc. Click to Find Verastem Oncology decision makers emails.
What types of cancer does Verastem Oncology focus on?
Verastem Oncology primarily focuses on developing treatments for hematologic cancers, particularly non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL), and T-cell lymphoma. The company is dedicated to advancing therapies that target these specific types of blood cancers, aiming to improve patient outcomes and quality of life.
What is the role of clinical trials in Verastem Oncology's development process?
Clinical trials are a critical component of Verastem Oncology's development process. They are conducted to evaluate the safety and efficacy of new treatments before they can be approved for general use. Verastem actively engages in various phases of clinical trials to gather data that supports the development of innovative therapies for cancer patients. Participation in these trials is essential for advancing research and potentially bringing new treatment options to market.
How does Verastem Oncology approach cancer research and drug development?
Verastem Oncology employs a scientific approach to cancer research, focusing on understanding the underlying mechanisms of cancer biology. The company utilizes advanced technologies and methodologies to identify novel therapeutic targets and develop drugs that can effectively combat cancer. Their commitment to innovation drives the discovery and development of new medicines aimed at addressing unmet medical needs in oncology.
What is the significance of Verastem Oncology's commitment to patients?
Verastem Oncology is deeply committed to improving the lives of patients diagnosed with cancer. This commitment is reflected in their focus on developing targeted therapies that not only aim to treat the disease but also enhance the overall quality of life for patients. By prioritizing patient needs and experiences, Verastem strives to create meaningful advancements in cancer treatment and support the cancer community.
Can patients participate in Verastem Oncology's clinical trials?
Yes, patients can participate in Verastem Oncology's clinical trials, provided they meet specific eligibility criteria. Participation in clinical trials offers patients access to cutting-edge therapies that are not yet widely available. Interested individuals should consult with their healthcare providers to determine if they qualify for any ongoing trials and to understand the potential benefits and risks associated with participation.
What resources does Verastem Oncology provide for healthcare professionals?
Verastem Oncology offers a range of resources for healthcare professionals, including detailed information about their clinical trials, research findings, and treatment options for hematologic cancers. These resources aim to support healthcare providers in making informed decisions regarding patient care and treatment strategies. Additionally, Verastem may provide educational materials and updates on the latest advancements in oncology to keep professionals informed about new developments in the field.
